×
About 7,774 results

ALLMedicine™ Vitiligo Center

Research & Reviews  3,723 results

The Impact of Vitiligo on Quality of Life and Psychosocial Well-Being in a Nepalese Pop...
https://doi.org/10.1016/j.det.2020.08.011
Dermatologic Clinics; Pun J, Randhawa A et. al.

Nov 24th, 2020 - The authors collected demographics and assessed the impact of vitiligo using Vitiligo Quality of Life (VitiQoL) and Vitiligo Impact Scale (VIS), followed by a focused survey and semistructured interviews with 22 participants in midwestern Nepal. V...

Associations of methylenetetrahydrofolate reductase gene (MTHFR) rs1801131 and rs180113...
https://doi.org/10.1111/jocd.13857
Journal of Cosmetic Dermatology; Zhang HZ, Wu JH et. al.

Nov 21st, 2020 - Vitiligo is a common pigmentary skin disorder and genetic factors were acknowledged to be greatly associated with the pathogenesis of this disease. Recently, increasing studies investigated the associations of methylenetetrahydrofolate reductase (...

Comparison of the efficacy of broad-band targeted UVB phototherapy and topical psoralen...
https://doi.org/10.1111/dth.14562
Dermatologic Therapy; Dincer Rota D, Aksoy Sarac G et. al.

Nov 21st, 2020 - To compare efficacy of targeted broad-band UVB phototherapy and topical psoralen with targeted UVA phototherapy treatments in localized vitiligo for three months prospectively. The cases with symmetrical vitiligo lesions were included in the study...

The Unfolded Protein and Integrated Stress Response in Melanoma and Vitiligo.
https://doi.org/10.1111/pcmr.12947
Pigment Cell & Melanoma Research; Manga P, Choudhury N

Nov 20th, 2020 - Epidermal melanocytes are constantly exposed to environmental stressors such as ultraviolet light (UV) and chemotoxins. Several evolutionarily conversed survival mechanisms are deployed to ensure melanocyte recovery after damage including the unfo...

Pembrolizumab induced vitiligo in a patient with lung adenocarcinoma: a case report.
https://doi.org/10.1111/bcp.14663
British Journal of Clinical Pharmacology; Bulat V, Likic R et. al.

Nov 20th, 2020 - Pembrolizumab is an immune checkpoint inhibitor designed to block the interaction between programmed death-1 and programmed death-ligand 1 and 2. It shows efficacy in the treatment of patients with advanced non-small cell lung cancer, among others...

see more →

Guidelines  3 results

Guidelines for the diagnosis and treatment of vitiligo in Japan.
https://doi.org/10.1111/1346-8138.12099
The Journal of Dermatology; Oiso N, Suzuki T et. al.

Feb 27th, 2013 - Vitiligo is an acquired pigment disorder in which depigmented macules result from the loss of melanocytes from the involved regions of skin and hair. The color dissimilarity on the cosmetically sensitive regions frequently induces quality of life ...

Guidelines for the management of vitiligo: the European Dermatology Forum consensus.
https://doi.org/10.1111/j.1365-2133.2012.11197.x
The British Journal of Dermatology; Taieb A, Alomar A et. al.

Aug 6th, 2012 - The aetiopathogenic mechanisms of vitiligo are still poorly understood, and this has held back progress in diagnosis and treatment. Up until now, treatment guidelines have existed at national levels, but no common European viewpoint has emerged. T...

Guideline for the diagnosis and management of vitiligo.
https://doi.org/10.1111/j.1365-2133.2008.08881.x
The British Journal of Dermatology; Gawkrodger DJ, Ormerod AD et. al.

Nov 27th, 2008 - This detailed and user-friendly guideline for the diagnosis and management of vitiligo in children and adults aims to give high quality clinical advice, based on the best available evidence and expert consensus, taking into account patient choice ...

see more →

Drugs  3 results see all →

Clinicaltrials.gov  3,803 results

The Impact of Vitiligo on Quality of Life and Psychosocial Well-Being in a Nepalese Pop...
https://doi.org/10.1016/j.det.2020.08.011
Dermatologic Clinics; Pun J, Randhawa A et. al.

Nov 24th, 2020 - The authors collected demographics and assessed the impact of vitiligo using Vitiligo Quality of Life (VitiQoL) and Vitiligo Impact Scale (VIS), followed by a focused survey and semistructured interviews with 22 participants in midwestern Nepal. V...

Associations of methylenetetrahydrofolate reductase gene (MTHFR) rs1801131 and rs180113...
https://doi.org/10.1111/jocd.13857
Journal of Cosmetic Dermatology; Zhang HZ, Wu JH et. al.

Nov 21st, 2020 - Vitiligo is a common pigmentary skin disorder and genetic factors were acknowledged to be greatly associated with the pathogenesis of this disease. Recently, increasing studies investigated the associations of methylenetetrahydrofolate reductase (...

Comparison of the efficacy of broad-band targeted UVB phototherapy and topical psoralen...
https://doi.org/10.1111/dth.14562
Dermatologic Therapy; Dincer Rota D, Aksoy Sarac G et. al.

Nov 21st, 2020 - To compare efficacy of targeted broad-band UVB phototherapy and topical psoralen with targeted UVA phototherapy treatments in localized vitiligo for three months prospectively. The cases with symmetrical vitiligo lesions were included in the study...

The Unfolded Protein and Integrated Stress Response in Melanoma and Vitiligo.
https://doi.org/10.1111/pcmr.12947
Pigment Cell & Melanoma Research; Manga P, Choudhury N

Nov 20th, 2020 - Epidermal melanocytes are constantly exposed to environmental stressors such as ultraviolet light (UV) and chemotoxins. Several evolutionarily conversed survival mechanisms are deployed to ensure melanocyte recovery after damage including the unfo...

Pembrolizumab induced vitiligo in a patient with lung adenocarcinoma: a case report.
https://doi.org/10.1111/bcp.14663
British Journal of Clinical Pharmacology; Bulat V, Likic R et. al.

Nov 20th, 2020 - Pembrolizumab is an immune checkpoint inhibitor designed to block the interaction between programmed death-1 and programmed death-ligand 1 and 2. It shows efficacy in the treatment of patients with advanced non-small cell lung cancer, among others...

see more →

News  223 results

Topical Corticosteroid and Home-based Narrowband UVB for Localised Vitiligo
https://www.medscape.com/viewarticle/938697

Oct 8th, 2020 - Takeaway Combination treatment with hand-held narrowband-ultraviolet B (NB-UVB) light and potent topical corticosteroid (TCS) is likely to result in improved treatment response in patients with localised non-segmental vitiligo compared with potent...

Narrowband UVB for Vitiligo Linked to Lower Fracture Risk
https://www.medscape.com/viewarticle/937667

Sep 20th, 2020 - NEW YORK (Reuters Health) - Vitiligo patients who receive long-term narrowband UVB phototherapy are at lower risk of major osteoporotic fractures, new research shows. "Systemic phototherapy to treat vitiligo can unexpectedly reduce the risk of fra...

Dermatology therapies evolve as disease knowledge and investment grow
https://www.mdedge.com/dermatology/article/219314/medical-dermatology/dermatology-therapies-evolve-disease-knowledge-and/page/0/2?channel=27980

Mar 19th, 2020 - Spillover to other diseases JAK inhibitors – some in oral and some in topical form – are showing efficacy in ongoing research for alopecia areata (AA) and vitiligo as well, Dr. Blauvelt said.

Vitiligo tied to lower risk of internal malignancies
https://www.mdedge.com/dermatology/article/217491/pigmentation-disorders/vitiligo-tied-lower-risk-internal-malignancies?channel=39313
Bruce Jancin

Feb 19th, 2020 - LAHAINA, HAWAII – Individuals with vitiligo demonstrated a markedly reduced rate of internal malignancies in a recent first-of-its-kind “big data” study from South Korea, Iltefat Hamzavi, MD, said at the Hawaii Dermatology Seminar provided by Glob.

Pembrolizumab-Induced Lobular Panniculitis in the Setting of Metastatic Melanoma
https://www.mdedge.com/dermatology/article/216730/melanoma/pembrolizumab-induced-lobular-panniculitis-setting-metastatic?channel=44
Caitlin M. Peterman, MD, Leslie Robinson-Bostom, MD et. al.

Feb 5th, 2020 - To the Editor: Pembrolizumab is an anti–programmed death receptor 1 humanized monoclonal antibody used for treating advanced or metastatic melanoma. 1 It is associated with several immune-related adverse events because it blocks a T-cell receptor c.

see more →

Patient Education  19 results see all →